Equities

InnerScope Hearing Technologies, Inc.

INND:PKL

InnerScope Hearing Technologies, Inc.

Actions
  • Price (USD)0.0003
  • Today's Change0.000 / -16.67%
  • Shares traded33.72m
  • 1 Year change-85.29%
  • Beta--
Data delayed at least 15 minutes, as of May 28 2024 20:08 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

InnerScope Hearing Technologies, Inc. is a manufacturer and distributor of over the counter (OTC) hearing aids, hearing aid accessories and hearing health-related products (Hearing Products). Its hearing products and its business-to-consumer (B2C) and business-to-business model break through the persistent barriers that prevent access to hearing solutions. The Hearing Kiosk is designed for Americans with undetected/untreated perceived mild-to-moderate hearing losses to treat themselves with the Company's OTC hearing aids offered in-store off-the-shelf and/or OTC online affordable hearing aid options. It relies on several third-party suppliers for the components used in its hearing aids, including semiconductor components, such as integrated circuits, as well as batteries, microphones and receivers. Its full line of Hearing Products is available through these multiple retail/wholesale distribution channels: Walmart Vision Centers, Walmart.com, Walmart Canada, CVS, CVS.com and others.

  • Revenue in USD (TTM)334.45k
  • Net income in USD-7.15m
  • Incorporated2012
  • Employees24.00
  • Location
    InnerScope Hearing Technologies, Inc.2151 PROFESSIONAL DRIVE, 2ND FLOORROSEVILLE 95661United StatesUSA
  • Phone+1 (916) 218-4100
  • Websitehttps://innd.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Kelyniam Global Inc517.70k-420.28k1.68m0.00--3.13--3.24-0.0253-0.02530.03120.01790.41357.044.38---33.57---41.79--18.86---81.18--1.26--0.6232---26.47---19.10------
Bone Biologics Corp0.00-6.10m1.75m2.00--0.4398-----23.10-23.100.003.620.00----0.00-114.93-98.31-189.37--------------0.00-------502.76------
VirExit Technologies Inc0.00-1.80m1.99m-----------0.0932-0.1130.00-0.03670.00-------6,103.43-----------------3.66-----100.00--19.08------
Aethlon Medical, Inc.574.25k-12.26m2.14m15.00--0.1448--3.73-5.03-5.030.23622.930.0369----38,283.33-78.62-75.30-92.02-84.98-----2,133.17-1,783.78----0.00--95.2130.86-15.55--106.99--
NanoVibronix Inc2.85m-3.20m2.16m10.00--0.6168--0.7583-1.72-1.721.451.260.5160.368313.64285,000.00-57.98-116.16-101.17-169.3668.9850.47-112.35-570.471.38-13.470.00--203.5948.3331.88---34.02--
Dynatronics Corp33.60m-5.14m2.22m154.00--0.298--0.0662-1.19-1.197.583.041.103.338.31218,173.30-14.35-6.02-19.94-8.3021.3727.33-13.07-4.550.6787-12.560.2188---8.41-8.81-19.84---5.11--
Tivic Health Systems Inc1.13m-7.61m2.53m9.00--0.2804--2.23-11.17-11.171.021.460.21840.923717.31126,000.00-146.51---194.55--30.07---670.99--2.07--0.00---36.09--18.34------
Nu-Med Plus Inc0.00-119.16k2.55m2.00---------0.0014-0.00140.00-0.0020.00----0.00-350.01-447.69---------------22.74--------3.56------
InnerScope Hearing Technologies, Inc.334.45k-7.15m2.67m24.00------8.00-0.0153-0.01530.0002-0.00280.09553.931.71---204.11-27.82---94.5317.7958.17-2,138.50-42.130.0022-0.4232------100.59----233.50--
Tenon Medical Inc3.21m-14.33m2.69m21.00--8.28--0.8356-7.24-7.241.430.97240.41082.787.25153,047.60-183.10---269.43--54.70---445.77--2.35--0.00--323.73--17.63------
Vycor Medical Inc1.44m-425.52k2.94m8.00------2.04-0.0133-0.01350.0425-0.10781.590.66726.81179,572.50-11.22-47.86----89.4889.60-7.04-35.420.0861-0.0247----19.43-0.654246.49---31.77--
Therapeutic Solutions International Inc98.99k-2.17m2.96m3.00--2.37--29.91-0.0007-0.00070.000030.00030.02871.134.4432,996.67-64.51-162.32-169.11--62.8567.79-2,247.41-2,391.850.0333-4.920.373---52.1395.3543.11------
Helius Medical Technologies Inc-100.00bn-100.00bn3.14m26.00--0.5544----------2.24-----------98.37---143.57--37.27---1,580.663.26-------18.176.1437.11------
Invo Bioscience Inc4.25m-7.08m3.43m25.00------0.8068-5.68-5.682.590.00390.34739.5030.72169,953.20-57.87-94.63-128.00-151.4539.9074.91-166.64-343.110.1629-5.860.9965--267.3843.6226.24--87.09--
Venus Concept Inc73.30m-37.39m3.44m304.00------0.0469-6.69-6.6913.12-3.540.74091.062.21241,125.00-37.61-32.71-56.83-44.0168.3768.16-50.77-48.501.35-3.441.40---23.2628.3114.76---35.08--
Data as of May 28 2024. Currency figures normalised to InnerScope Hearing Technologies, Inc.'s reporting currency: US Dollar USD

Institutional shareholders

0.00%Per cent of shares held by top holders
HolderShares% Held
HBC Financial Services PLLCas of 31 Mar 20240.000.00%
ORG Partners LLCas of 31 Mar 20240.000.00%
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.